Skip to content

Clinical trials

Terminated Phase 3 Parkinson Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 3 Status: Terminated Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20051
20062
20073
20082
20092
20102
20111
20134
20142
20151
20171
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adamas Pharmaceuticals, Inc.2
Biotie Therapies Inc.2
Eisai Limited2
Merck Sharp & Dohme LLC2
Newron Pharmaceuticals SPA2
Theravance Biopharma2
Biogen1
Chelsea Therapeutics1
Eisai Inc.1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease26
Dyskinesias5
Parkinsonian Disorders3
Pure Autonomic Failure3
Dizziness2
Hypotension2
Hypotension, Orthostatic2
Syncope2
Deglutition Disorders1
Dementia1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.